Literature DB >> 27660781

High-Quality Draft Genome Sequence of the Multidrug-Resistant Clinical Isolate Enterococcus faecium VRE16.

Suelen Scarpa de Mello1, Daria Van Tyne2, Andrei Nicoli Gebieluca Dabul3, Michael S Gilmore4, Ilana L B C Camargo5.   

Abstract

Specific lineages of the commensal bacterium Enterococcus faecium belonging to CC17, especially ST412, have been isolated from patients in several hospitals worldwide and harbor antibiotic resistance genes and virulence factors. Here, we report a high-quality draft genome sequence and highlight features of E. faecium VRE16, a representative of this ST.
Copyright © 2016 de Mello et al.

Entities:  

Year:  2016        PMID: 27660781      PMCID: PMC5034132          DOI: 10.1128/genomeA.00992-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Infections caused by vancomycin-resistant Enterococcus (VRE) are increasingly difficult to treat and often cause prolonged hospital outbreaks (1). In the case of E. faecium, these challenges appear to be caused by the expansion and dissemination of strains belonging to the clonal complex (CC) 17 (2). In Brazil, E. faecium strains belonging to sequence type (ST) 412 (part of CC17) are often found in hospitalized patients (3–6). Recently, vanA-containing E. faecium ST412 was found in urban rivers (Tietê River and Pinheiros River) in Sao Paulo, the largest and most populous metropolitan area in Brazil, underscoring the importance of this lineage as a major public health threat (7). E. faecium VRE16 is an ST412 strain, isolated from a perianal swab collected from a male patient on 3 September 2009, during a surveillance program in the Intensive Care Unit of Risoleta Tolentino Neves Hospital–MG/Brazil. It is representative of the endemic VRE E. faecium strains found within this hospital in that year. VRE16 is resistant at high levels to vancomycin, teicoplanin, erythromycin, ampicillin, penicillin, and streptomycin (3). Genomic DNA of VRE16 was extracted using a DNeasy blood and tissue kit (Qiagen, USA). DNA libraries were prepared using an Illumina Nextera XT DNA sample preparation kit (Illumina Inc., USA), with recommended modifications for 2 × 250-bp paired-end sequencing. Samples were multiplexed and sequenced on an Illumina MiSeq machine (Illumina Inc., USA). CLC Genomics Workbench version 8.0.2 (CLCBio, Denmark) was used for genome assembly, using default parameters. The genome was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (8). The entire vancomycin resistance-encoding transposon Tn1546 (10.8 kb) was amplified by long-range PCR, as described by Woodford et al. (9). Overlapping PCR was performed following the protocol of Arthur et al. (10), and the fragments were sequenced to identify the insertion sequences present in them. IS16, exclusively prevalent among hospital E. faecium strains from an international collection of isolates, was amplified by PCR using a previously described protocol (11). Sequencing/assembly generated 8,172,175 reads, with a total size of 2,897,665 bp, an N50 value of 1,495,544 bp, a GC content of 37.8%, and 594-fold coverage. The following antibiotic resistance genes were found by ResFinder (http://www.genomicepidemiology.org): vanA (glycopeptide resistance), aph(3′)-III and ant(6)-Ia (aminoglycoside resistance), msr(C) (macrolide, lincosamide and streptogramin B resistance), and erm(B) (macrolide resistance). Regarding the characteristics of Tn1546, the element conferring vancomycin resistance, VRE16 lacks the right inverted repeat (IRR). IS1251 was inserted within the vanS-vanH genes at the same position as already observed in other Brazilian isolates (4, 6, 7, 12), and IS1216E was inserted between vanX and vanY after nucleotide 8649 (position according to the reference sequence M97297.1 in NCBI). VRE16 was positive for the hospital marker IS16 and has the virulence genes acm and efaAfm. Since CC17 represents a significant problem in hospitals worldwide, E. faecium VRE16 has been used as a standard strain for searching new compounds with in vitro antibacterial activity, as an initiative of the Center for Innovation in Biodiversity and Drug Discovery (CIBFar: http://cibfar.ifsc.usp.br/english).

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number LSYW00000000. The version described in this paper is the first version, LSYW01000000.
  11 in total

1.  Environmental dissemination of vanA-containing Enterococcus faecium strains belonging to hospital-associated clonal lineages.

Authors:  Andrey G Sacramento; Louise T Cerdeira; Lara M de Almeida; Rosemeire C Zanella; Carlos Pires; Maria I Z Sato; Emanuela A S Costa; Natasha P Roberto; Elsa M Mamizuka; Nilton Lincopan
Journal:  J Antimicrob Chemother       Date:  2015-10-12       Impact factor: 5.790

2.  Investigation by long PCR of the genetic elements mediating VaNa glycopeptide resistance in enterococci from uncooked meat in south Manchester.

Authors:  N Woodford; A P Watson; P R Chadwick
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

3.  Genetic features and molecular epidemiology of Enterococcus faecium isolated in two university hospitals in Brazil.

Authors:  Leila Priscilla Pinheiro da Silva; André Pitondo-Silva; Roberto Martinez; Ana Lúcia da Costa Darini
Journal:  Diagn Microbiol Infect Dis       Date:  2012-09-06       Impact factor: 2.803

4.  Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital.

Authors:  Thaís Panhan Merlo; Andrei Nicoli Gebieluca Dabul; Ilana Lopes Baratella Cunha Camargo
Journal:  Microb Drug Resist       Date:  2015-01-14       Impact factor: 3.431

5.  Changes in vancomycin-resistant Enterococcus faecium causing outbreaks in Brazil.

Authors:  I C V Palazzo; A Pitondo-Silva; C E Levy; A L da Costa Darini
Journal:  J Hosp Infect       Date:  2011-07-07       Impact factor: 3.926

6.  Enterococcus gallinarum carrying the vanA gene cluster: first report in Brazil.

Authors:  I L B C Camargo; A L Barth; K Pilger; B G S Seligman; A R L Machado; A L C Darini
Journal:  Braz J Med Biol Res       Date:  2004-10-26       Impact factor: 2.590

Review 7.  Vancomycin-resistant enterococci.

Authors:  Ethan Rubinstein; Yoav Keynan
Journal:  Crit Care Clin       Date:  2013-10       Impact factor: 3.598

Review 8.  Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen.

Authors:  Janetta Top; Rob Willems; Marc Bonten
Journal:  FEMS Immunol Med Microbiol       Date:  2008-02-14

9.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

Authors:  M Arthur; C Molinas; F Depardieu; P Courvalin
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

10.  Emergence of vanA vancomycin-resistant Enterococcus faecium in a hospital in Porto Alegre, South Brazil.

Authors:  Mariah Resende; Juliana Caierão; Juliana Gil Prates; Gabriel Azambuja Narvaez; Cícero Armídio Gomes Dias; Pedro Alves d'Azevedo
Journal:  J Infect Dev Ctries       Date:  2014-02-13       Impact factor: 0.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.